Retraction: a novel combination of Chinese medicines to treat advanced cancers and lymphomas tested in rats

The author has withdrawn this article [1] from the public domain because they did not have permission to use the data that was presented within. In the light of this situation, BioMed Central regrets that this article is no longer available. The author apologises to all parties for the inconvenience...

Descripción completa

Detalles Bibliográficos
Autor principal: Waterhouse, Dawn N
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848050/
https://www.ncbi.nlm.nih.gov/pubmed/20233405
http://dx.doi.org/10.1186/1749-8546-5-10
_version_ 1782179639831035904
author Waterhouse, Dawn N
author_facet Waterhouse, Dawn N
author_sort Waterhouse, Dawn N
collection PubMed
description The author has withdrawn this article [1] from the public domain because they did not have permission to use the data that was presented within. In the light of this situation, BioMed Central regrets that this article is no longer available. The author apologises to all parties for the inconvenience.
format Text
id pubmed-2848050
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28480502010-04-01 Retraction: a novel combination of Chinese medicines to treat advanced cancers and lymphomas tested in rats Waterhouse, Dawn N Chin Med Retraction The author has withdrawn this article [1] from the public domain because they did not have permission to use the data that was presented within. In the light of this situation, BioMed Central regrets that this article is no longer available. The author apologises to all parties for the inconvenience. BioMed Central 2010-03-16 /pmc/articles/PMC2848050/ /pubmed/20233405 http://dx.doi.org/10.1186/1749-8546-5-10 Text en Copyright ©2010 Waterhouse; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Waterhouse, Dawn N
Retraction: a novel combination of Chinese medicines to treat advanced cancers and lymphomas tested in rats
title Retraction: a novel combination of Chinese medicines to treat advanced cancers and lymphomas tested in rats
title_full Retraction: a novel combination of Chinese medicines to treat advanced cancers and lymphomas tested in rats
title_fullStr Retraction: a novel combination of Chinese medicines to treat advanced cancers and lymphomas tested in rats
title_full_unstemmed Retraction: a novel combination of Chinese medicines to treat advanced cancers and lymphomas tested in rats
title_short Retraction: a novel combination of Chinese medicines to treat advanced cancers and lymphomas tested in rats
title_sort retraction: a novel combination of chinese medicines to treat advanced cancers and lymphomas tested in rats
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848050/
https://www.ncbi.nlm.nih.gov/pubmed/20233405
http://dx.doi.org/10.1186/1749-8546-5-10
work_keys_str_mv AT waterhousedawnn retractionanovelcombinationofchinesemedicinestotreatadvancedcancersandlymphomastestedinrats

Ejemplares similares